Database research and development often require a large number of SQL queries for benchmarking purposes. However, acquiring real-world SQL queries is challenging due to privacy concerns, and existing ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

docker build -t fund-traceability-engine:local .